KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $213.1 million.

  • West Pharmaceutical Services' Other Accumulated Expenses rose 3377.28% to $213.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $213.1 million, marking a year-over-year increase of 3377.28%. This contributed to the annual value of $188.2 million for FY2024, which is 2126.29% up from last year.
  • As of Q3 2025, West Pharmaceutical Services' Other Accumulated Expenses stood at $213.1 million, which was up 3377.28% from $222.8 million recorded in Q2 2025.
  • West Pharmaceutical Services' Other Accumulated Expenses' 5-year high stood at $222.8 million during Q2 2025, with a 5-year trough of $136.5 million in Q3 2023.
  • For the 5-year period, West Pharmaceutical Services' Other Accumulated Expenses averaged around $168.7 million, with its median value being $163.4 million (2021).
  • As far as peak fluctuations go, West Pharmaceutical Services' Other Accumulated Expenses skyrocketed by 4854.56% in 2021, and later crashed by 1556.04% in 2023.
  • Over the past 5 years, West Pharmaceutical Services' Other Accumulated Expenses (Quarter) stood at $163.4 million in 2021, then grew by 12.48% to $183.8 million in 2022, then decreased by 15.56% to $155.2 million in 2023, then grew by 21.26% to $188.2 million in 2024, then rose by 13.23% to $213.1 million in 2025.
  • Its Other Accumulated Expenses was $213.1 million in Q3 2025, compared to $222.8 million in Q2 2025 and $186.4 million in Q1 2025.